Group 1 - The upcoming National Day and Mid-Autumn Festival holiday is expected to see increased travel, necessitating health and safety precautions for travelers [1] - The transition between seasons is a peak period for respiratory diseases, highlighting the importance of personal protective measures such as wearing masks and maintaining hand hygiene in crowded places [2] - Recommendations for managing common ailments like flu and cold include using medications containing acetaminophen for fever and pain relief, and specific cold medications for symptoms like sneezing and nasal congestion [2] Group 2 - Travelers prone to motion sickness should prepare motion sickness medication in advance, with specific guidelines for usage timing and caution regarding children's medication [3] - In case of injuries during travel, it is advised to carry antiseptic supplies and band-aids, and to seek medical attention for serious injuries while applying ice for swelling [4] - Attention to food safety is crucial during the holiday, with recommendations to avoid undercooked foods and to be cautious with food storage and consumption [6][7]

Group 1 - The World Health Organization (WHO) stated that there is currently no conclusive scientific evidence linking the use of acetaminophen by pregnant women to an increased risk of autism in their children [1] - WHO highlighted that nearly 62 million people globally are affected by autism spectrum disorders, which are a group of diverse conditions related to brain development [1] - Extensive research over the past decade has not established a fixed association between the use of acetaminophen during pregnancy and autism in children [1] Group 2 - WHO confirmed that there is substantial reliable evidence indicating that childhood vaccines do not cause autism, supported by large-scale, high-quality studies conducted in many countries [2] - Independent experts advising WHO since 1999 have repeatedly affirmed that all vaccines, including those containing thimerosal or aluminum, do not lead to autism or other developmental disorders [2]

Group 1 - The article discusses the significant impact of Trump and Kennedy on the U.S. public health system, suggesting it is on the brink of collapse [2][34] - Trump's recent announcement linking acetaminophen use during pregnancy to autism has raised concerns, despite a lack of scientific evidence supporting this claim [3][8][34] - The article highlights the historical context of conspiracy theories surrounding autism and acetaminophen, noting that previous studies have not found a correlation [5][8][12] Group 2 - The rise of conspiracy theories in the U.S. has been linked to a growing distrust in modern medicine, exacerbated by the COVID-19 pandemic [31][34] - The article emphasizes the importance of societal trust in the medical system, stating that without it, even advanced medical technologies cannot be effective [34] - It suggests that the current political climate, driven by figures like Trump and Kennedy, is eroding the foundational trust in the healthcare system [34][32]

Core Viewpoint - The recent statement by President Trump regarding the potential risk of acetaminophen (Tylenol) use during pregnancy and its association with autism has sparked significant discussion and concern in the medical community and among pharmaceutical companies [1][3]. Group 1: Company Responses - The manufacturer of Tylenol, after reviewing existing scientific evidence, maintains that acetaminophen does not cause autism, a view supported by credible public health and medical professionals [3]. - The company emphasizes the importance of consulting healthcare professionals before taking any over-the-counter medications during pregnancy [3][5]. Group 2: Regulatory and Scientific Perspectives - The FDA has been monitoring the topic for over a decade and has conducted multiple reviews since 2014, maintaining its recommendation for acetaminophen use during pregnancy without changing the drug's labeling information [3]. - The World Health Organization (WHO) stated that while some observational studies suggest a potential link between prenatal exposure to acetaminophen and autism, the existing evidence is inconsistent, with several studies finding no such association [4]. - The European Medicines Agency has not found any evidence linking Tylenol use during pregnancy to autism, and there is currently no need to modify existing recommendations in the EU [4]. Group 3: Medical Community Insights - Experts highlight that autism is a complex neurodevelopmental disorder with rising global prevalence, currently estimated at about 1%, with significant increases observed in the U.S. from 1 in 150 in 2000 to 1 in 44 in 2020 [4][5]. - Medical professionals advise that while acetaminophen remains a primary choice for fever and pain relief during pregnancy, it is crucial to weigh the risks and benefits and to avoid unnecessary use [5].

每经记者｜兰素英 王嘉琦 每经编辑｜段炼 高涵 作为全球最常见的非处方退烧药之一，有关泰诺（Tylenol）的安全争议再度被拉到聚光灯下。 9月22日，美国政府提出，自闭症与孕妇使用对乙酰氨基酚之间存在未经证实的关联。对乙酰氨基酚是泰诺的活性成分。 此举立即引发市场的剧烈震动，泰诺制造商科赴（Kenvue）的股价当天下挫7.47%，收盘跌至历史最低点。 在接受每日经济新闻记者（以下简称"每经记者"）采访时，科赴中国表示，在评估既有的科学证据后，该公司"依然坚信服用对乙酰氨基酚不会导致自闭 症"。 医学界专家也对特朗普政府的这一说法表示了强烈反驳。他们认为，白宫的声明"没有得到全部科学证据的支持"，并警告不治疗发烧本身可能对胎儿造成 危害。 泰诺 对乙酰氨基酚于20世纪50年代作为阿司匹林的处方替代品引入美国。到20世纪70年代，它已成为非处方药，并成为美国最常用的止痛退烧药之一。 根据2014年发表在《美国家庭医生》杂志上的一项研究，40%至65%的女性在孕期会服用对乙酰氨基酚。 特朗普表示，自闭症病例的上升是一场"可怕的危机"，他对此"深感忧虑"。 据美国疾病控制与预防中心（CDC），自2000年以来，自闭 ...

Group 1 - U.S. stock market showed mixed results with Nasdaq down 0.04%, S&P 500 up 0.01%, and Dow Jones up 0.27% [1] - TSMC's stock rose over 3%, reaching a new high, with reports indicating a 20% price increase for the third-generation 3nm process compared to the previous generation, and a projected 50% price increase for the 2nm process to be supplied next year [1] - Boeing's stock increased by over 2% following an $8 billion order from Uzbekistan Airways, with Turkey also planning to purchase hundreds of American aircraft [1] Group 2 - Kenvue, the parent company of Tylenol, saw its stock rise over 7% after the WHO stated there is no consistent evidence linking prenatal exposure to acetaminophen with autism [1]

Group 1 - Kenvue's stock increased by 5.9% after refuting claims that acetaminophen may lead to autism [1] - Boeing's shares rose by 2.7% following an order from Uzbekistan Airways valued at over $8 billion [1] - Firefly Aerospace's stock fell by 10.9% as Q2 losses exceeded expectations and revenue was also below forecasts [1] Group 2 - AutoZone's stock declined by 2.3% due to Q4 performance falling short of expectations [1] - TSMC's stock increased by 3.9%, reaching a new high, with reports indicating a 20% price increase for the third-generation 3nm process compared to the previous generation [1]

Core Viewpoint - The article discusses the impact of President Trump's warning to pregnant women about the use of Tylenol (acetaminophen), linking it to autism, which led to a significant drop in Kenvue's stock price. However, medical professionals and Kenvue refute this claim, stating there is no scientific evidence supporting such a connection [2][3][7]. Group 1: Stock Market Reaction - Kenvue's stock price fell over 7% to a historical low of $32.57, resulting in a market capitalization of $32.567 billion (approximately 231.6 billion RMB) following Trump's warning [3]. - Following the backlash and lack of scientific support for Trump's claims, Kenvue's stock rebounded by over 5% in pre-market trading [2][3]. Group 2: Medical Community Response - Numerous doctors and Kenvue have stated that there is no scientific evidence linking acetaminophen to autism, emphasizing that such claims could endanger the health of pregnant women [2][7]. - The FDA has indicated that there is no clear evidence that appropriate use of acetaminophen during pregnancy leads to adverse outcomes [5]. Group 3: Research and Studies - A large-scale study published in 2024 analyzing data from nearly 2.5 million siblings in Sweden found no increased risk of autism in children whose mothers used acetaminophen during pregnancy [4]. - The article notes that the diagnosis rate of autism has significantly increased in the U.S., with 1 in 31 children diagnosed, compared to 1 in 150 in 2000, although the reasons for this rise remain unclear [6]. Group 4: Government and Pharmaceutical Company Actions - U.S. health officials are expected to issue warnings against the use of Tylenol during early pregnancy unless necessary, while also promoting a drug called Leucovorin as a potential treatment for autism [8]. - Kenvue has added a section on its website to address media reports, reiterating that there is no evidence linking acetaminophen to autism [7].

Group 1 - US stock index futures show mixed performance with Nasdaq futures down 0.04%, S&P 500 futures down 0.02%, and Dow futures up 0.16% [1] - European stock indices collectively rise, with Germany's DAX up 0.45%, UK's FTSE 100 up 0.18%, France's CAC up 0.97%, and Euro Stoxx 50 up 0.73% [2] - Goldman Sachs raises its year-end target for the S&P 500 index from 6600 to 6800 points [4] - Nvidia plans to invest up to $100 billion in OpenAI and co-develop AI data centers [5] - Meta's AI system Llama receives approval for use from the US government's General Services Administration (GSA) [6] - Alibaba's Qwen team is set to release six new items, including one product, two open-source models, and three API interfaces [7] - TSMC's third-generation 3nm process is rumored to increase prices by approximately 20%, while the 2nm process may see a 50% price increase [10] - Kenvue, the parent company of Tylenol, asserts that independent and reliable scientific evidence shows that acetaminophen does not cause autism [9] - Walmart expands its pharmacy delivery service to include home delivery of refrigerated prescription medications [11] - HSBC launches cross-border tokenized deposit services, with Ant International as its first client [12] - Kinsan Cloud plans to issue 282 million shares, with 80% of the raised funds allocated to support AI business [14] - Saudi Prince Alwaleed increases his stake in Snap by acquiring 15.2 million shares, raising his ownership to 2.8% [15]

Group 1 - Kenvue's stock experienced a decline of approximately 7.5% yesterday, followed by a pre-market rebound of over 6%, reaching $18.02 [1] - President Trump warned pregnant women against using Tylenol, citing a potential link between acetaminophen and autism, despite the lack of widely accepted scientific evidence [1] - Kenvue issued a statement asserting confidence in independent and reliable scientific evidence that acetaminophen does not cause autism, strongly opposing contrary claims [1]